RGEN Q4 2024 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$168M+7.6% YoY

Gross Profit

$39M23.2% margin

Operating Income

-$37M-21.8% margin

Net Income

-$34M-20.2% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

+8.2%

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

$32M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$857M

Stockholders' Equity

$2.0B

Cash & Equivalents

$757M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$168M	$156M	+7.6%
Gross Profit	$39M	$68M	-42.5%
Operating Income	-$37M	-$887,000	-4015.1%
Net Income	-$34M	-$25M	-32.9%

Revenue Segments

Product

$174M100%